Speaker Profile

Senior Manager, Partnerships, PathAI

Biography
Robert Brockett has spent most of his career as a scientist in histopathology, developing immunohistochemistry assays and image analysis strategies. He has a M.S. degree in Clinical and Translational Research, a B.S. in Biology, and is a certified Histotechnologist.


AI and Data Science Showcase:
PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.

AI-Powered Pathology for Prospective Clinical Trials
Learn about PathAI's clinical trial and drug development AI tools for patient selection, endpoint analysis, or manual reads quality control

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.